Accéder au contenu
Merck
  • Monoamine receptor agonists, acting preferentially at presynaptic autoreceptors and heteroreceptors, downregulate the cell fate adaptor FADD in rat brain cortex.

Monoamine receptor agonists, acting preferentially at presynaptic autoreceptors and heteroreceptors, downregulate the cell fate adaptor FADD in rat brain cortex.

Neuropharmacology (2014-10-07)
M Julia García-Fuster, Jesús A García-Sevilla
RÉSUMÉ

FADD is a crucial adaptor of death receptors that can engage apoptosis or survival actions (e.g. neuroplasticity) through its phosphorylated form (p-FADD). Although FADD was shown to participate in receptor mechanisms related to drugs of abuse, little is known on its role in the signaling of classic neurotransmitters (dopamine, noradrenaline, and serotonin) in brain. This study assessed the modulation of FADD (and p-FADD/FADD ratio, as an index of neuroplasticity) and FLIP-L (a neuroprotective FADD interacting partner), as well as the role of MEK-ERK signaling, after activation of monoamine auto/heteroreceptors by selective agonists in rat cortex. Acute depletion of monoamines with reserpine, but not with AMPT or PCPA, reduced FADD (28%) and increased p-FADD/FADD ratio (1.34-fold). Activation of presynaptic α2A-adrenoceptors (UK-14304 and clonidine), 5-HT1A receptors (8-OH-DPAT), and D2 dopamine receptor (bromocriptine) dose-dependently decreased FADD (up to 54%) and increased p-FADD (up to 29%) and p-FADD/FADD ratios (up to 2.93-fold), through specific receptor mechanisms. Activation of rat 5-HT1B autoreceptor in axon terminals by CP-94253 did not modulate FADD forms. Activation of postsynaptic D1 dopamine receptor by SKF-81297 also reduced FADD (25%) and increased p-FADD (32%). Disruption of MEK-ERK activation with SL327 did not modify clonidine (α2A-adrenoceptor)-induced FADD inhibition, indicating that agonist effect was not dependent on ERK signaling. The various monoamine receptor agonists and antagonists did not alter FLIP-L content, or the activation of executioner caspase-3 and PARP-1 cleavage, indicating that the agonists attenuated apoptotic signals and promoted neuroplasticity through FADD regulation. These novel results indicate that inhibition of pro-apoptotic FADD adaptor could function as a common signaling step in the initial activation of monoamine receptors in the brain.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acide chlorhydrique, ACS reagent, 37%
Sigma-Aldrich
Acide chlorhydrique, ACS reagent, 37%
Sigma-Aldrich
Dodécylsulfate de sodium, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
Chlorure d'hydrogène solution, 4.0 M in dioxane
Sigma-Aldrich
Dodécylsulfate de sodium, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
Acide chlorhydrique solution, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Hydrobromic acid, ACS reagent, 48%
Sigma-Aldrich
Acide chlorhydrique, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
Dodécylsulfate de sodium solution, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
Acide chlorhydrique, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
Acide chlorhydrique, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Chlorure d'hydrogène solution, 2.0 M in diethyl ether
Supelco
Acide chlorhydrique solution, volumetric, 0.1 M HCl (0.1N), endotoxin free
Sigma-Aldrich
Dodécylsulfate de sodium solution, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
Hydrobromic acid, reagent grade, 48%
Sigma-Aldrich
Dodécylsulfate de sodium, BioUltra, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Hydrogen bromide solution, 33 wt. % in acetic acid
Sigma-Aldrich
Hydrobromic acid, 48 wt. % in H2O, ≥99.99%
Sigma-Aldrich
Chlorure d'hydrogène solution, 1.0 M in diethyl ether
Supelco
Dodécylsulfate de sodium, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Acide chlorhydrique solution, ~6 M in H2O, for amino acid analysis
Sigma-Aldrich
Benzyl cyanide, 98%
Sigma-Aldrich
2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, ≥99%
Sigma-Aldrich
Dodécylsulfate de sodium, ≥98.0% (GC)
Sigma-Aldrich
Chlorure d'hydrogène solution, 3 M in cyclopentyl methyl ether (CPME)
Sigma-Aldrich
Dodécylsulfate de sodium, ACS reagent, ≥99.0%
Sigma-Aldrich
Acide chlorhydrique solution, 32 wt. % in H2O, FCC
Sigma-Aldrich
Reserpine
Sigma-Aldrich
4-Chloro-DL-phenylalanine
Sigma-Aldrich
Clonidine hydrochloride, solid